Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02145091 · ClinicalTrials.gov registry record · Phase 1
Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT02145091: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT02145091 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02145091, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a double-blind placebo-controlled study investigating the acute and persisting effects of psilocybin on meditation, spirituality, health, well-being, prosocial attitudes, and brain functioning.
Interventions
- DRUG Placebo
- DRUG Moderately-high dose of psilocybin
- DRUG Moderately-low dose of psilocybin
- DRUG Very-low dose of psilocybin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-05 |
| Est. Completion | 2019-12-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02145091
The ClinicalTrials.gov registry entry for NCT02145091 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02145091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02145091 about?
NCT02145091 is a clinical study titled "Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators". This is a double-blind placebo-controlled study investigating the acute and persisting effects of psilocybin on meditation, spirituality, health, well-being, prosocial attitudes, and brain functioning.
What is the current status of trial NCT02145091?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2014-05. Estimated completion is 2019-12-26.
What interventions are being tested in trial NCT02145091?
The interventions under investigation include: Placebo (DRUG), Moderately-high dose of psilocybin (DRUG), Moderately-low dose of psilocybin (DRUG), Very-low dose of psilocybin (DRUG).
Who is sponsoring clinical trial NCT02145091?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.